Synonym
LAS194046; LAS 194046; LAS-194046
IUPAC/Chemical Name
(R)-3-(3-((6-(4-(4-(2-(dimethylamino)ethoxy)benzyl)piperazin-1-yl)-5-fluoro-2-(pyrazolo[1,5-a]pyridin-3-yl)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
InChi Key
IOSNQXYLFHEZTC-AREMUKBSSA-N
InChi Code
InChI=1S/C34H41FN10O2/c1-41(2)20-21-47-27-10-8-25(9-11-27)23-42-16-18-43(19-17-42)34-31(35)33(38-26-6-5-14-44(24-26)30(46)12-13-36)39-32(40-34)28-22-37-45-15-4-3-7-29(28)45/h3-4,7-11,15,22,26H,5-6,12,14,16-21,23-24H2,1-2H3,(H,38,39,40)/t26-/m1/s1
SMILES Code
FC(C(N[C@@H]1CCCN(C(CC#N)=O)C1)=N2)=C(N3CCN(CC4=CC=C(OCCN(C)C)C=C4)CC3)N=C2C5=C6N(N=C5)C=CC=C6
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
640.77
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Milara J, Ballester B, de Diego A, Calbet M, Ramis I, Miralpeix M, Cortijo J.
The pan-JAK inhibitor LAS194046 reduces neutrophil activation from severe asthma
and COPD patients in vitro. Sci Rep. 2022 Mar 24;12(1):5132. doi:
10.1038/s41598-022-09241-6. PMID: 35332239; PMCID: PMC8948298.
2: Calbet M, Ramis I, Calama E, Carreño C, Paris S, Maldonado M, Orellana A,
Calaf E, Pauta M, De Alba J, Bach J, Miralpeix M. Novel Inhaled Pan-JAK
Inhibitor, LAS194046, Reduces Allergen-Induced Airway Inflammation, Late
Asthmatic Response, and pSTAT Activation in Brown Norway Rats. J Pharmacol Exp
Ther. 2019 Aug;370(2):137-147. doi: 10.1124/jpet.119.256263. Epub 2019 May 13.
PMID: 31085698.